Indiana University Research and Technology Corporation
发明人:
Craig A. Erickson
申请号：
US15192535
公开号：
US20160303057A1
申请日:
2016.06.24
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Subjects who were diagnosed with either comorbid or idiopathic autism were treated with acamprosate. Patients generally showed marked improvements in primary outcomes as assessed using, for example, standard clinic measures for functionality including the Clinical Global Impressions Improvement (CGI-I) and the Clinical Global Impressions Severity (CGI-S) scales.
